Understanding post-COVID-19 interstitial lung disease: a new fibroinflammatory disease entity.

Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity – Intensive Care Medicine

Commentary on Twitter

Post #COVID19 interstitial lung disease?
? PC-ILD fibroinflammatory disease
? etiopathogenesis
Identifying risk factors & understanding immunopathomechanisms critical to facilitate early intervention to prevent, slow or arrest lung damage progression.
?https://t.co/OEM2W9bAEd pic.twitter.com/m4w4qUXl9r

— Intensive Care Medicine (@yourICM) September 8, 2022